XOMA as of Nov 4 · 13:00 ET
XOMANasdaqPharmaceutical Preparations
XOMA Royalty Corp · Brief
Next report
5 days
Nov 9 · before openest.Q3 FY26
Expected move
No implied move.
0 of 8≥ implied
- avg implied
- ±16.2%
- avg realized
- ±6.0%
Aug 13 '24±17.0%▲+14.40%×0.85
Nov 7 '24±15.9%▼−6.96%×0.44
Mar 17 '25±18.9%▲+0.77%×0.04
May 13 '25±16.7%▲+10.89%×0.65
Aug 13 '25±9.9%▲+8.54%×0.86
Q3 FY25±12.3%▼−2.52%×0.21
Mar 2 '26±22.0%▲+2.66%×0.12
Q1 FY26±17.0%▲+1.30%×0.08
quarterimplied−25%0+25%realized×
Q1 FY26±17.0%▲+1.30%×0.08
Mar '26±22.0%▲+2.66%×0.12
Q3 FY25±12.3%▼−2.52%×0.21
Aug '25±9.9%▲+8.54%×0.86
May '25±16.7%▲+10.89%×0.65
Mar '25±18.9%▲+0.77%×0.04
2 older reports
Nov '24±15.9%▼−6.96%×0.44
Aug '24±17.0%▲+14.40%×0.85
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 9 report · est.Bull2 of 3
Bear2 of 3
AI captions · Nov 2 '26once per report · top 2 per case
Linked exposure
XOMA report sessionCustomers 1
× = co-movement · max 436dSource: SEC filings · market data
No changes.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.